Atlas Trials

Study of URC102 to Assess the Safety and Efficacy in Gout Patients

Clinical trial NCT02557126 · COMPLETED

Trial details

NCT number
NCT02557126
Sponsor
JW Pharmaceutical
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
GoutHyperuricemia
Start date
2015-10-01
Primary completion
2016-08-01
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.